FDA Brief

Company record

"Daniel C. Tarquinio, D.O./Center for Rare Neurological Diseases

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about "Daniel C. Tarquinio, D.O./Center for Rare Neurological Diseases.

Warning letters

  1. "Daniel C. Tarquinio, D.O./Center for Rare Neurological Diseases

    FDA warns clinical investigator Daniel C. Tarquinio over enrolling ineligible subjects in investigational drug trials.

    High risk